Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insulet Co. (NASDAQ:PODD – Get Rating) has received a consensus rating of “Hold” from the fourteen research firms that are presently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price objective among brokerages that […]
Cigna Investments Inc. New acquired a new position in shares of Insulet Co. (NASDAQ:PODD – Get Rating) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 747 shares of the medical instruments supplier’s stock, valued at approximately $220,000. A number of other hedge […]
Simplify Asset Management Inc. bought a new stake in Insulet Co. (NASDAQ:PODD – Get Rating) in the 4th quarter, HoldingsChannel reports. The firm bought 873 shares of the medical instruments supplier’s stock, valued at approximately $257,000. Several other large investors also recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew […]
Insulet Co. (NASDAQ:PODD – Get Rating) shares were down 5.6% during trading on Thursday . The stock traded as low as $274.26 and last traded at $277.23. Approximately 204,643 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 711,383 shares. The stock had previously closed at $293.75. Analyst […]
StockNews.com started coverage on shares of Insulet (NASDAQ:PODD – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a hold rating on the medical instruments supplier’s stock. Several other research analysts have also weighed in on PODD. Stifel Nicolaus upped their target price on shares of Insulet from $300.00 […]